Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More
Meet the Kit Check Pharmacists
From day one, Kit Check has been committed to making pharmacy-first product innovations. Our flagship RFID medication management system was born out of a dinner conversation Kit Check CEO and co-founder Kevin MacDonald had with a pharmacist friend. Since then, we have been designing products based on interactions with pharmacy and healthcare professionals every day. We have four pharmacists on … Read More
New Bluesight for Controlled Substances Feature: Investigation Portfolios
We are excited to announce the launch of our newest feature for the Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Designed to support ASHP investigation guidelines, the Investigations Portfolio dashboard allows hospital diversion teams to collaborate with each other throughout the process, ensuring thorough, unbiased investigations and adherence to established procedures. Many hospitals … Read More
Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios
Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of a new feature to its Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Bluesight for Controlled Substances’ Investigation Portfolios tool was designed … Read More
Kit Check Partners with Sandoz to Help Improve Drug Administration Safety
We are thrilled to announce our commercial and supply agreement with Sandoz that will allow Sandoz generic injectable products to operate out of the box in any Kit Check customer site without any additional labor. Kit Check and Sandoz will provide a complete solution for manufacturers and contract manufacturing organizations (CMOs) that want to implement RFID tagging in facilities that … Read More
Kit Check and Sandoz agree to a commercialization collaboration that helps improve hospital medication administration safety
Implementation of Kit Check RFID technology enables accuracy and visibility of hospital medications, from the production line to the patient Washington DC, June 27, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, along with Sandoz, a Novartis division, today announced a commercialization and supply agreement that will allow Sandoz generic injectable products to operate out … Read More
‘Works With Kit Check’ Helps Hospitals Drive Toward the Next Generation of Drug Tracking
Last December we were thrilled to announce “Works with Kit Check” – a program that certifies hospital solutions that are compatible with Kit Check’s pharmacy kit management software. Since the original announcement, we have seen tremendous interest throughout the pharmacy community. Now, we are looking to expand the reach and diversity of the program so more organizations receive this certification … Read More
Kit Check Brings Next-Generation Medication Tracking Mainstream with FDA Pilot
Pilot looks to implement tech that improves the tracking of powerful drugs and interoperability of software throughout the supply chain Group initiative brings together industry leaders such as Nephron Pharmaceuticals, Sandoz, Coral Gables Hospital and Hackensack University Medical Center Washington DC, June 11, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the acceptance … Read More
Webinar: The Diversion Gap and What to Do About It
Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what we call the diversion gap—the space between controlled substance dispense activity and documentation where inventory can go missing. Hosted by IHFDA, the webinar covers key findings from our 2018 Hospital Pharmacy Operations Report, especially as they relate to the opioid crisis. AJ discusses the need … Read More
Nurses Unite: Impacting Change Around the Opioid Epidemic
This week we come together to celebrate the bravery, compassion, and determination of nurses. There are currently more than four million nurses practicing in the United States, and they are some of the most trusted professionals across any industry. Amid today’s opioid epidemic, which has claimed the lives of over 70,000 Americans, the American Nurses Association (ANA) recognizes the critical … Read More
Hospital Pharmacy Operations Report Shows Half of All Hospitals Have Experienced Drug Diversion in the Last Six Months and Points to Lack of Visibility, Tools and Resources
Kit Check, the leader in automated medication management solutions for hospitals, today announced the findings of its 2018 Hospital Pharmacy Operations Report, which surveyed pharmacy leaders affiliated with over 1,000 hospitals across the United States. The findings are published on the heels of a recent analysis of 1 million controlled substance cases which was executed utilizing Kit Check’s artificial intelligence solution for drug diversion, Bluesight for Controlled Substances.
Survey of Hospital Pharmacy Directors Reveals Drug Shortages are Top Issue
Hospital pharmacy directors say drug shortage management was their top challenge in 2018. Other top issues include meeting requirements without increased budget, increasing pharmacy’s role in patient care, and drug diversion events. The fifth annual edition of the Hospital Pharmacy Operations Report (HPOR) captured insights from pharmacy leaders that impact over 1,000 hospitals. Over 75% of the respondents were directors … Read More